Edenor S.A. ADR (EDN) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q4 24	-$0.08	$0.8	+1100.0%	—	$630.5B	—
Q3 24	-$0.01	$2.93	+29400.0%	—	$392.8M	—
Q2 24	-$0.05	$1.15	+2400.0%	—	$436.7B	—
Q1 24	$2.68	$1.32	-50.7%	—	$276.2B	—
Q4 23	-$5.96	-$0.01	+99.8%	—	$322.3B	—
Q3 23	$5.05	$4.97	-1.6%	—	$427.3B	—
Q4 22	—	-$0.02	—	—	$70B	—
Q2 22	—	-$0.26	—	—	$79.1B	—
Q4 21	—	-$0.24	—	—	$32.7B	—
Q2 21	—	-$0.13	—	—	$39.2B	—
Q1 19	-$0.14	-$2.13	-1421.4%	—	$23.6B	—
Q4 18	—	$0.05	—	—	$21.2B	—
Q3 18	-$0.05	$0.6	+1300.0%	—	$23.7B	—
Q2 18	-$0.19	-$0.14	+26.3%	—	$15.1B	—
Q1 18	$2.3	$1.31	-43.0%	—	$17.6B	—
Q4 17	$0.4	$0.03	-92.5%	—	$6.8B	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY25	—	$5.5K	—	—	$3T	—
FY24	—	$6.2K	—	—	$2T	—
FY23	—	$1.1K	—	—	$701.1B	—
FY22	—	-$399.2	—	—	$641B

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	$25.8B	$60.9B	$117.1B	$184.7B	$268.4B	$688.5B	$641B	$701.1B	$2T	$3T
YoY change	+579.3%	+135.8%	+92.3%	+57.7%	+45.3%	+156.5%	-6.9%	+9.38%	+191.4%	+46.4%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	25.8B	60.9B	117.1B	184.7B	268.4B	688.5B	641B	701.1B	2T	3T
Cost of revenue	25.3B	46.2B	89.6B	150.3B	228.7B	600B	617.7B	673.4B	1.6T	2.3T
Gross profit	573.3M	14.7B	27.6B	34.4B	39.7B	88.5B	23.3B	27.7B	394.6B	680.6B
Gross margin	2.22%	24.1%	23.5%	18.6%	14.8%	12.9%	3.64%	3.95%	19.3%	22.8%
Research & development	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	5.5B	7.5B	11.8B	21.7B	25.9B	77.6B	97B	113.9B	274B	378.6B
Operating expenses	5.9B	8.3B	11.7B	21.6B	23.2B	66.1B	89.1B	102.3B	246.7B	361.6B
Operating income	-5.7B	3.7B	9.8B	9.9B	-6.9B	-21.4B	-95.9B	-119.1B	45.5B	149.6B
Operating margin	-22.2%	6.14%	8.36%	5.37%	-2.57%	-3.11%	-15%	-17%	2.23%	5%
Non-operating income, net	8.4B	8.2B	13.6B	49.9B	-28.7B	157.3B	376.1B	637.1B	656.4B	546.5B
Pretax income	388M	8.6B	12.9B	46.8B	-62.5B	-34.6B	-8.2B	182.2B	193.3B	291.3B
Income tax	147.3M	784.3M	3.9B	21.9B	-10.5B	94.8B	46.2B	133.8B	-78.8B	52.1B
Net income	240.8M	7.8B	9B	24.9B	-52B	-129.5B	-54.4B	48.4B	272.1B	239.2B
Net margin	0.93%	12.8%	7.68%	13.5%	-19.4%	-18.8%	-8.49%	6.9%	13.3%	8%
EBITDA	5.4B	16.1B	32.9B	78.7B	42.2B	174B	315.1B	601.8B	36B	479.3B
EPS	-26.6	15.2	96.6	276.8	-404.6	-487.8	-399.2	1.1K	6.2K	5.5K
Diluted EPS	-26.6	15.2	96.6	276.8	-404.6	-487.8	-399.2	1.1K	6.2K	5.5K

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	427.3B	322.3B	276.2B	436.7B	392.8M	630.5B	638.5B	661.4B	740.8B	872.6B	846.7B	918.5B
Cost of revenue	360.1B	324.2B	234.1B	318.6B	320.7M	526.3B	507.1B	509.7B	540.3B	660.2B	610.9B	736.9B
Gross profit	67.3B	-1.9B	42.1B	118.1B	72.1M	104.2B	131.4B	121.2B	200.6B	212.4B	235.8B	181.7B
Gross margin	15.7%	-0.59%	15.2%	27.1%	18.4%	16.5%	20.6%	18.3%	27.1%	24.3%	27.9%	19.8%
Research & development	—	—	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	72B	59.6B	55.3B	69B	63.1M	81.6B	70.5B	105.7B	146.9B	134.1B	131.2B	149B
Operating expenses	65.3B	54.1B	52.6B	73.8B	67.3M	59.3B	70B	103.5B	137.7B	131.9B	101.5B	134.5B
Operating income	1.9B	-78.3B	-22B	44.3B	4.7M	15B	24.8B	9.8B	62.9B	45.9B	134.4B	47.2B
Operating margin	0.45%	-24.3%	-7.97%	10.1%	1.21%	2.38%	3.89%	1.48%	8.49%	5.26%	15.9%	5.14%
Non-operating income, net	622.1B	294.1B	127.1B	127.5B	63.3M	190.9B	86.3B	226.5B	77.9B	158.4B	110.8B	77.2B
Pretax income	421.3B	49.5B	-14.8B	39.4B	94.1M	35.6B	35.9B	125.9B	41.7B	75.8B	174.6B	17.9B
Income tax	186.4B	54B	-65.6B	-7.9B	13.3M	-1.5B	37M	32.9B	1.1B	16.1B	56.8B	-13.4B
Net income	234.9B	-4.5B	50.9B	47.3B	80.9M	37.1B	35.9B	92.9B	40.6B	59.8B	117.9B	31.3B
Net margin	55%	-1.41%	18.4%	10.8%	20.6%	5.88%	5.62%	14.1%	5.49%	6.85%	13.9%	3.41%
EBITDA	618B	268.4B	219.5B	99.6B	170.6M	-69.9B	48.3B	176.7B	66.2B	113.4B	197.3B	89.6B
EPS	5.4K	—	1.2K	1.1K	2.6K	—	820.8	2.1K	928.8	—	2.7K	715.6
Diluted EPS	5.4K	—	1.2K	1.1K	2.6K	—	820.8	2.1K	928.8	—	2.7K	715.6

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Market cap	1.3T	2.3T	1.3T	288.5B	195B	243.7B	367.5B	924.6B	—	1.3B	962.4M
Enterprise value	1.3T	2.3T	1.3T	297.7B	197.9B	227.7B	320.4B	930.7B	—	397.8B	274.3M
Shares outstanding	47.1B	47.2B	46.8B	46.1B	46B	46B	46B	47.7B	43.8M	43.8M	43.8M

Valuation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
P/E	5.5K	300.4	140.8	11.6	—	—	—	19.1	—	0.01	6.22
P/S	50.8	38.5	10.8	1.56	0.73	0.35	0.57	1.32	—	0	0
P/B	3.6K	84.4	26.6	3.58	2.05	1.7	0.94	2.11	—	0	0.5
EV/EBITDA	242.7	145.9	38.6	3.78	4.69	1.31	1.02	1.55	—	0.83	0.83
EV/Sales	50.9	38.6	10.9	1.61	0.74	0.33	0.5	1.33	—	0.13	0.14
Earnings yield	0.02%	0.33%	0.71%	8.64%	—	—	—	5.23%	—	18.3K%	16.1%
FCF yield	0.06%	-0.04%	0.22%	0.56%	11.3%	16.5%	3.14%	-5.23%	—	-13.5K%	-7.78%
PEG	—	—	—	—	—	—	—	—	—	—	-0.09

Profitability

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Gross margin	2.22%	24.1%	23.5%	18.6%	14.8%	12.9%	3.64%	3.95%	19.3%	22.8%	19.8%
Operating margin	-22.2%	6.14%	8.36%	5.37%	-2.57%	-3.11%	-15%	-17%	2.23%	5%	5.14%
Net margin	0.93%	12.8%	7.68%	13.5%	-19.4%	-18.8%	-8.49%	6.9%	13.3%	8%	7.2%
ROE	66.5%	28.1%	18.9%	31%	-54.8%	-90.2%	-13.9%	11%	18.1%	10.8%	9.59%
ROA	1.27%	11%	7.6%	15.3%	-23.2%	-27.9%	-3.64%	3.21%	6.84%	4.15%	3.09%
ROIC	-381.5%	11.4%	12.8%	5.88%	-7.04%	-16.8%	-27.9%	-7.11%	2.87%	4.69%	7.33%
Return on tangible assets	1.27%	11%	7.6%	15.3%	-23.2%	-27.9%	-3.64%	3.21%	6.84%	4.15%	3.52%

Financial health

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Current ratio	0.69	0.74	0.65	0.74	0.55	0.43	0.42	0.65	0.89	1.07	1.46
Quick ratio	0.67	0.71	0.59	0.66	0.51	0.4	0.39	0.54	0.75	0.91	1.28
Debt / equity	7.8	0.23	0.27	0.17	0.14	0.14	0.12	0.22	0.32	0.54	0.62
Debt / assets	0.15	0.09	0.11	0.08	0.06	0.04	0.03	0.06	0.12	0.21	0.24
Net debt / EBITDA	0.11	0.12	0.17	0.12	0.07	-0.09	-0.15	0.01	2.19	0.83	0.93
Interest coverage	1.15	3.18	2.24	4.38	-1.29	0.79	0.97	1.57	1.58	1.95	1.96
Effective tax rate	38%	9.12%	30.4%	46.8%	0%	0%	0%	73.4%	0%	17.9%	19.5%

Per share

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Revenue per share	0.55	1.29	2.5	4.01	5.84	15	13.9	14.7	46.7K	68.4K	70.3K
EPS (basic)	-26.6	15.2	96.6	276.8	-404.6	-487.8	-399.2	1.1K	6.2K	5.5K	5.5K
EPS (diluted)	-26.6	15.2	96.6	276.8	-404.6	-487.8	-399.2	1.1K	6.2K	5.5K	3.33
Book value per share	0.01	0.59	1.02	1.75	2.06	3.12	8.51	9.19	34.4K	50.8K	41.6
FCF per share	0.02	-0.02	0.06	0.04	0.48	0.87	0.25	-1.01	-2.6K	-4K	-2.6K
Cash per share	0.05	0.09	0.15	0.09	0.22	0.8	2.05	1.92	9.1K	18.2K	29.4K
Capex per share	0.09	0.26	0.37	0.42	0.63	1.94	2.15	2.51	8.2K	—	—

Capital allocation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Capex / revenue	16.4%	19.9%	14.8%	10.4%	10.8%	13%	15.4%	17.1%	17.6%	—	—
Capex / operating cash flow	-143.1%	131.6%	245.9%	182.3%	-157.4%	74.1%	114%	6.5K%	220.5%	—	—
Payout ratio	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%
Dividend yield	0%	0%	0%	0%	0%	0%	0%	0%	—	0%	0%

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	$427.3B	$322.3B	$276.2B	$436.7B	$392.8M	$630.5B	$638.5B	$661.4B	$740.8B	$872.6B	$846.7B	$918.5B
YoY change	+277.1%	+360.2%	+1.99%	+27.9%	-99.9%	+95.6%	+131.2%	+51.4%	+188.5K%	+38.4%	+32.6%	+38.9%

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Cash & short-term investments	2.3B	4.4B	7.1B	4.4B	10.1B	36.8B	94.5B	91.8B	397.5B	796.3B
Receivables	2.5B	4.2B	6.1B	9.1B	12.6B	18.8B	39.4B	32.4B	156.2B	307.7B
Inventory	230.3M	589.3M	1.9B	2.5B	2.8B	6.7B	20B	39.8B	149.8B	233.3B
Total current assets	6.6B	13.7B	21.1B	24.7B	35.2B	81.8B	259.9B	232.2B	966.3B	1.6T
Property, plant & equipment	600.9M	-7.9B	-7.9B	-13.5B	-32.5B	-72.6B	-245.9B	-250.6B	-430B	-760.7B
Goodwill & intangibles	—	—	—	—	—	—	—	—	—	—
Total assets	18.9B	70.9B	118.4B	163B	224.5B	463.3B	1.5T	1.5T	4T	5.8T
Accounts payable	4B	6.6B	12.6B	17.3B	49.8B	128.9B	485.2B	195.9B	622.7B	333.2B
Short-term debt	53.7M	105.1M	1.7B	2.4B	433M	20.5B	2B	52.8B	116.4B	483.9B
Total current liabilities	9.6B	18.5B	32.3B	33.5B	63.6B	190B	618.9B	355.7B	1.1T	1.5T
Long-term debt	2.8B	6.2B	11.1B	11.2B	12.6B	154M	45.4B	45.1B	360B	708.8B
Total liabilities	18.6B	43.1B	70.8B	82.1B	129.6B	319.7B	1.1T	1.1T	2.5T	3.5T
Shareholders' equity	361.8M	27.8B	47.6B	80.5B	94.9B	143.6B	391.3B	438.8B	1.5T	2.2T
Total debt	2.8B	6.3B	12.7B	13.6B	13B	20.7B	47.4B	97.9B	476.4B	1.2T
Net debt	2.6B	6.2B	12.7B	13B	6.4B	14.5B	42.3B	88.8B	452.4B	985.7B

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Cash & short-term investments	60B	91.8B	169.5B	177B	178.8M	397.5B	372.4B	387.5B	484.8B	796.3B	769.5B	1.3T
Receivables	35B	32.4B	81.9B	112B	118.7M	156.2B	214.5B	199.3B	233.1B	307.7B	320.4B	340.9B
Inventory	21.1B	39.8B	76.2B	108.2B	90.4M	149.8B	172.4B	190.3B	210.6B	233.3B	253.7B	265.1B
Total current assets	181.6B	232.2B	504.2B	619B	564.4M	966.3B	1T	1.1T	1.2T	1.6T	1.6T	2.1T
Property, plant & equipment	-166.2B	-250.6B	-366.1B	-412B	-310.1M	-430B	-508.7B	2.5T	-605.1B	-760.7B	-862.4B	-960.9B
Goodwill & intangibles	—	—	—	—	—	—	—	—	—	—	—	—
Total assets	1T	1.5T	2.5T	3T	2.5B	4T	4.3T	4.7T	5.1T	5.8T	6.2T	7.1T
Accounts payable	109.5B	195.9B	345.6B	408.3B	376.6M	622.7B	759.6B	459.9B	458.9B	333.2B	522.4B	699.1B
Short-term debt	2.3B	52.8B	57B	132.9B	114.7M	116.4B	78.1B	130.8B	260.6B	483.9B	371.6B	364.7B
Total current liabilities	194.4B	355.7B	637.5B	813.4B	688.4M	1.1T	1.2T	1.1T	1.2T	1.5T	1.3T	1.5T
Long-term debt	40.7B	45.1B	128.1B	85.6B	117.8M	360B	375.2B	423.8B	551B	708.8B	785.2B	1.3T
Total liabilities	703.2B	1.1T	1.7T	2.1T	1.7B	2.5T	2.7T	2.8T	3.1T	3.5T	3.6T	4.3T
Shareholders' equity	308.2B	438.8B	716.2B	896.5B	791.2M	1.5T	1.7T	1.9T	2T	2.2T	2.6T	2.8T
Total debt	43B	97.9B	185.1B	218.5B	232.5M	476.4B	453.3B	554.6B	811.6B	1.2T	1.2T	1.7T
Net debt	35.2B	88.8B	159.9B	217B	230.7M	452.4B	442.8B	495.4B	774.3B	985.7B	991.4B	1.2T

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Net income	240.8M	7.8B	9B	24.9B	-52B	-129.5B	-54.4B	48.4B	272.1B	239.2B
Depreciation & amortization	2.1B	3.3B	5.4B	9.8B	20B	58B	59.9B	85.6B	165.2B	210.7B
Stock-based compensation	32.8M	17.6M	22M	0	—	—	—	—	—	—
Change in working capital	969.7M	2.5B	-2.4B	400M	30.1B	83.7B	130.4B	65.3B	81.6B	-598.9B
Operating cash flow	-3B	9.2B	7B	10.6B	-18.4B	120.6B	86.6B	1.8B	163.3B	192B
Capital expenditure	-4.2B	-12.1B	-17.3B	-19.2B	-28.9B	-89.3B	-98.8B	-119.8B	-360B	—
Investing cash flow	-4.1B	-12.8B	-17.4B	-4.5B	-34B	-155B	-116.3B	-79.1B	-567.2B	-33.1B
Dividends paid	0	0	0	0	0	0	0	0	0	0
Share repurchases	0	0	-2.2B	-1.2B	0	0	—	—	—	—
Financing cash flow	-696.5M	2B	-3B	-8.1B	-15.4B	-3.3B	-12B	9.2B	295.9B	527.2B
Net change in cash	-7.7B	-1.6B	-13.4B	-2.1B	-67.8B	-37.6B	-41.8B	-68B	-108.1B	686.1B
Free cash flow	742.7M	-970.5M	2.8B	1.6B	22B	40.2B	11.5B	-48.3B	-114B	-176.4B

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Net income	227.2B	-4.5B	50.9B	-6B	33.2M	37.1B	35.9B	83.4B	4.5B	59.8B	117.9B	39.3B
Depreciation & amortization	53.3B	47.7B	26.6B	38.1B	15M	53.7B	40.2B	33.7B	25.2B	69.3B	56.2B	66.9B
Stock-based compensation	—	—	—	—	—	—	—	—	—	—	—	—
Change in working capital	10.3B	47.6B	-8.2B	-80.9B	-17.4M	183.8B	-2.8B	-362.5B	-39.7B	-133.2B	-57.5B	59B
Operating cash flow	-26.6B	-4.3B	-102.7B	-155B	160.7M	157.7B	61B	9.2B	-8B	55.9B	60.8B	96.1B
Capital expenditure	-86.9B	-60.3B	-42.7B	-83.6B	-40.1M	-127.1B	-63.2B	—	—	—	—	—
Investing cash flow	-86.9B	-60.3B	-42.7B	-83.6B	-40.1M	-127.2B	-63.2B	—	—	-2.4B	—	—
Dividends paid	0	0	0	0	0	0	0	0	0	0	0	0
Share repurchases	—	—	—	—	—	—	—	—	—	—	—	—
Financing cash flow	623M	904M	74.8B	10.6B	43.4M	115.4B	-8.9B	7.3B	209.4B	323.7B	10B	424.9B
Net change in cash	-112.9B	-63.8B	-70.5B	-228B	164M	145.9B	-11.1B	16.5B	201.4B	377.3B	70.8B	521B
Free cash flow	-7B	-32.1B	-14.7B	-97.7B	-17.7M	-13.7B	11.2B	-49.2B	-68.3B	-62.3B	12.2B	3.1B

Edenor S.A. ADR Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement